Wave Life Sciences (WVE) Return on Capital Employed (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Return on Capital Employed for 11 consecutive years, with 0.62% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed fell 17.0% year-over-year to 0.62%, compared with a TTM value of 0.62% through Dec 2025, down 17.0%, and an annual FY2025 reading of 0.54%, up 1.0% over the prior year.
- Return on Capital Employed was 0.62% for Q4 2025 at Wave Life Sciences, up from 0.84% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.45% in Q4 2024 and bottomed at 2.09% in Q1 2023.
- Average Return on Capital Employed over 5 years is 1.03%, with a median of 0.88% recorded in 2025.
- The sharpest move saw Return on Capital Employed crashed -114bps in 2023, then soared 128bps in 2024.
- Year by year, Return on Capital Employed stood at 0.91% in 2021, then tumbled by -93bps to 1.76% in 2022, then rose by 24bps to 1.33% in 2023, then surged by 66bps to 0.45% in 2024, then crashed by -38bps to 0.62% in 2025.
- Business Quant data shows Return on Capital Employed for WVE at 0.62% in Q4 2025, 0.84% in Q3 2025, and 0.78% in Q2 2025.